Tipping the scales toward more effective antibodies

被引：27
作者：
Woof, JM [1 ]
机构：
[1] Univ Dundee, Sch Med, Ninewells Hosp, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland
来源：
SCIENCE | 2005年 / 310卷 / 5753期
关键词：
D O I：
10.1126/science.1122009
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
[No abstract available]
引用
收藏
页码：1442 / 1443
页数：2
相关论文
共 6 条
[1]   Fc receptor biology [J].
Daeron, M .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :203-234
[2]   Complement activation determines the therapeutic activity of rituximab in vivo [J].
Di Gaetano, N ;
Cittera, E ;
Nota, R ;
Vecchi, A ;
Grieco, V ;
Scanziani, E ;
Botto, M ;
Introna, M ;
Golay, J .
JOURNAL OF IMMUNOLOGY, 2003, 171 (03) :1581-1587
[3]   Divergent immunoglobulin G subclass activity through selective Fc receptor binding [J].
Nimmerjahn, F ;
Ravetch, JV .
SCIENCE, 2005, 310 (5753) :1510-1512
[4]   FcγRIV:: A novel FcR with distinct IgG subclass specificity [J].
Nimmerjahn, F ;
Bruhns, P ;
Horiuchi, K ;
Ravetch, JV .
IMMUNITY, 2005, 23 (01) :41-51
[5]   Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity [J].
Shields, RL ;
Lai, J ;
Keck, R ;
O'Connell, LY ;
Hong, K ;
Meng, YG ;
Weikert, SHA ;
Presta, LG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (30) :26733-26740
[6]   Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas [J].
Teeling, JL ;
French, RR ;
Cragg, MS ;
van den Brakel, J ;
Pluyter, M ;
Huang, H ;
Chan, C ;
Parren, PWHI ;
Hack, CE ;
Dechant, M ;
Valerius, T ;
van de Winkel, JGJ ;
Glennie, MJ .
BLOOD, 2004, 104 (06) :1793-1800
1